Discover how our AI severity classifier can transform your clinical trials.
Go beyond subjective patient-reported outcomes. Our proprietary machine vision model analyzes patient-submitted photos to generate an objective, validated severity score directly from the patient’s home.
We provide a single, adaptable solution to collect the real-world evidence that matters most. By combining objective AI-driven analysis with direct patient feedback, our platform helps you understand treatment efficacy more deeply, improve trial performance, and ultimately bring new therapies to patients faster.
Capture skin changes and symptom progression with our proprietary Machine Vision model, enabling accurate real-time therapy evaluation
Based on our generated data you can identify distinct patient subgroups who exhibit particularly favorable responses to specific therapies
Generate real-world insights from therapeutic responses and patient experiences in everyday environments, extending beyond conventional endpoints
Instant feedback to current condition promotes active patient engagement - reducing dropout rates, improved data integrity and compliance
Use our unique combination of real-world and image data to discover underlying patterns,reduce development costs and discover new treatment options
Images are processed instantly, providing immediate results without waiting times
AI analyzes different aspects of the skin condition simultaneously, creating a comprehensive evaluation
The system identifies and highlights specific characteristic, ensuring no important markers are missed in the assessment
Using established clinical scoring systems, ensuring consistent and comparable assessments across time and patients
A detailed report, including severity scores, affected area calculations, and recommended next steps
Seamlessly deploy standard or custom ePROs (electronic Patient-Reported Outcomes) and validated surveys. Capture the patient’s perspective consistently and in real-time, from quality of life questionnaires (e.g., DLQI, Skindex) to specific symptom diaries.
Empower patients to capture high-resolution photos of clinical signs. Our validated AI model analyzes the images to generate an objective severity score, providing consistent, unbiased visual evidence of treatment response or adverse events over time.
Gain a more holistic view of patient health by correlating symptoms with passively collected environmental data. Understand the impact of potential triggers like local pollen counts, UV index, or air quality to uncover novel insights.
Enhance your clinical practice with standardized assessments that ensure consistency across your patient base. Our AI-powered tool streamlines the documentation process, allowing you to efficiently monitor treatment progress with objective data. The time-efficient severity scoring system enables you to optimize your workflow while maintaining high-quality care standards. This enhanced approach to treatment planning, coupled with clear visual documentation, significantly improves communication with your patients about their condition and treatment progress.
Take control of your skin health with our user-friendly monitoring solution. From the comfort of your home, track your condition’s progression with professional-grade accuracy. Our system helps you better understand your skin’s changes over time, encouraging consistent treatment adherence through clear, visual progress tracking. The goal is that early detection features alert you to potential flare-ups, allowing for timely intervention. Plus, sharing standardized assessments with your healthcare provider ensures clear, effective communication about your condition.
Transform your clinical trials and research initiatives with our advanced assessment platform. Our standardized endpoint measurements ensure consistent, objective data collection across all study sites, significantly enhancing the quality of your drug development process. The remote monitoring capabilities streamline participant follow-up, while precise severity assessments improve recruitment accuracy. Experience substantial cost savings through efficient data collection and analysis, while generating valuable real-world evidence.
Nia Health is working on integration of our AI Severity Classifier into the Hospital Information System (KIS) of Charité - University Medicine Berlin, one of Europe's largest university hospitals. This strategic implementation will streamline the clinical workflow by enabling direct integration of AI-powered assessments into existing patient records.
Insights from medical data generated in the “real world” (real-world evidence) gives us unprecedented insights into the correlations around the incidence of diseases and symptoms. Through this integrated approach, our AI Severity Classifier creates a connected ecosystem that benefits all stakeholders in dermatological care, from clinical practice to research and development.
Industry Leaders on AI-Powered Assessment. How healthcare professionals and technology experts view the impact of our AI Severity Classifier.
The AI Severity Classifier represents a significant breakthrough in dermatology practice. Its ability to provide consistent, objective assessments has transformed how we monitor treatment progress.
The integration of the AI Severity Classifier into our clinical routine will mark a turning point in dermatological care. The technology combines precise diagnostics with efficient documentation and enables objective disease monitoring, which is invaluable for both patient care and clinical trials.
Chairman oder Clinic DirectorNia Health competed against more than 70 applicants and won the Deep Tech Award 2022.
Nia Health works with key stakeholders across the pharma and healthcare landscape.
Jonathan Silverberg, MD, PhD, MPH
Director of Clinical Research
George Washington School of Medicine
Ready to move beyond the limitations of traditional data collection? Let us demonstrate how our validated AI and real-world data streams can provide the objective, high-frequency evidence you need to prove efficacy and safety with greater confidence.
Our approach combines state-of-the-art machine learning with extensive dermatological expertise, resulting in a tool that sets new standards in objective disease assessment. What makes our solution unique is not just its technical sophistication, but its practical application in both clinical settings and research environments.
Oliver Welter CTO Nia Health